Evidence map›Paper›PMID 33571796›Full record

ArticleJournal of affective disorders2021

Letter to the editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.

Breno Souza-Marques, Rodrigo P Mello, Ana Paula Jesus-Nunes, Fernanda S Correia-Melo, Aline S Sampaio, Lucas C Quarantini

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of affective disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Breno Souza-MarquesPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil.
Rodrigo P MelloPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil.
Ana Paula Jesus-NunesPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil.
Fernanda S Correia-MeloPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil; Division of Psychiatry, Professor Edgard Santos University Hospital, Federal University of Bahia, Brazil.
Aline S SampaioPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil; Neuroscience and Mental Health Department, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil.
Lucas C QuarantiniPostgraduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil; Neuropsychopharmacology Laboratory, Federal University of Bahia, Salvador, Brazil; Division of Psychiatry, Professor Edgard Santos University Hospital, Federal University of Bahia, Brazil; Neuroscience and Mental Health Department, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil. Electronic address: lcq@ufba.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Depressive Disorder, Treatment-ResistantKetamineAdultDepressionDouble-Blind MethodHumansRandom AllocationEsketamineKetamineEsketamineKetamineTreatment-resistant depression

Identifiers

PMID33571796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.